Raffles Associates’s DNA X SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-167
Closed -$218K – 45
2020
Q4
$218K Sell
167
-83
-33% -$90.6K 0.25% 33
2020
Q3
$350K Buy
+250
New +$402K 0.59% 26

Other funds holding SONM

Raffles Associates's SONM Position: Q1 2021 in Review

Raffles Associates sold out of DNA X (SONM) in Q1 2021, closing a stake of 167 shares — an estimated $218K sold.

Raffles Associates first reported a position in SONM in Q3 2020 and held it in 2 quarters. The position peaked at $350K in Q3 2020. 23 funds tracked by Wall St. Rank hold SONM as of Q1 2021.

  • Raffles Associates reported no remaining DNA X position as of Q1 2021 after selling out during the quarter.
  • Raffles Associates sold 167 DNA X shares in Q1 2021, an estimated $218K.
  • Raffles Associates first reported a position in DNA X in Q3 2020 and held it in 2 quarters.
  • Raffles Associates's DNA X position peaked at $350K in Q3 2020.
  • 23 funds tracked by Wall St. Rank held DNA X as of Q1 2021.

Based on Raffles Associates's 13F filing for Q1 2021, filed 17 May 2021.